June 3, 2020 / 1:14 PM / a month ago

BRIEF-Aurobindo Pharma March Quarter Consol Profit Rises

June 3 (Reuters) - Aurobindo Pharma Ltd:

* MARCH QUARTER CONSOL NET PROFIT 8.5 BILLION RUPEES VERSUS 5.85 BILLION RUPEES

* MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 61.58 BILLION RUPEES VERSUS 52.92 BILLION RUPEES

* TRANSFER OF BIOSIMILARS,RELATED RESEARCH & DEVELOPMENT,MANUFACTURING FACILITIES IN INDRAKARAN VILLAGE ON GOING CONCERN BASIS TO UNIT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below